![Ton Logtenberg](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Ton Logtenberg
Vorsitzender bei Synox Therapeutics Ltd.
Aktive Positionen von Ton Logtenberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Utrecht Science Park | Direktor/Vorstandsmitglied | 01.11.2014 | - |
Jenner Vaccine Foundation | Direktor/Vorstandsmitglied | 01.01.2008 | - |
Hubrecht Organoid Technology Foundation | Direktor/Vorstandsmitglied | 01.08.2018 | - |
Synox Therapeutics Ltd.
![]() Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland. | Vorsitzender | 27.07.2021 | - |
Forbion Capital Partners Management Holding BV
![]() Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Private Equity Investor | 31.03.2022 | - |
Mestag Therapeutics Ltd.
![]() Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Vorsitzender | 20.12.2022 | - |
Direktor/Vorstandsmitglied | 01.01.2022 | 20.12.2022 |
Karriereverlauf von Ton Logtenberg
Ehemalige bekannte Positionen von Ton Logtenberg
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
MERUS N.V. | Direktor/Vorstandsmitglied | 16.06.2003 | 31.12.2019 |
Vorstandsvorsitzender | 16.06.2003 | 31.12.2019 | |
Finanzdirektor/CFO | - | 31.12.2019 | |
Gründer | 16.06.2003 | 31.12.2019 | |
Präsident | 16.06.2003 | 31.12.2019 | |
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Technik-/Wissenschafts-/F&E-Leiter | 01.07.2000 | 01.11.2003 |
Gründer | 01.07.2000 | 01.11.2003 | |
FORN EUROPAR | Direktor/Vorstandsmitglied | - | - |
Independent Dir/Board Member | - | - | |
░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | - | - |
Ausbildung von Ton Logtenberg
University of Utrecht | Doctorate Degree |
Statistik
International
Niederlande | 6 |
Vereinigtes Königreich | 3 |
Deutschland | 2 |
Operativ
Director/Board Member | 6 |
Founder | 2 |
Chairman | 2 |
Sektoral
Health Technology | 4 |
Finance | 4 |
Consumer Services | 2 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
MERUS N.V. | Health Technology |
Private Unternehmen | 8 |
---|---|
Crucell NV
![]() Crucell NV Pharmaceuticals: MajorHealth Technology Crucell NV develops, produces and markets vaccines, proteins and antibodies that prevent and treat infectious diseases. It focuses in the research & development of innovative immunization candidates to fight against tuberculosis, malaria, HIV/AIDS, influenza, rabies, polio and several other diseases which are the global health problems. The firms prod8ucts include Quinvaxem, Epaxal, Hepavax-Gene, Vivotif and Dukoral against paediatric, respiratory and travel or endemic infections. The company was founded by Domenico Valerio on October 9, 2000 and is headquartered in Leiden, Netherlands. | Health Technology |
Forbion Capital Partners Management Holding BV
![]() Forbion Capital Partners Management Holding BV Investment ManagersFinance Forbion Capital Partners Management Holding BV (Forbion) is a Netherlands-based venture capital firm which was founded by Bart Bergstein. Headquartered in Naarden, the firm specializes in late-stage and early-stage clinical development programs to optimize the commercial potential of their investee company's technologies. | Finance |
Jenner Vaccine Foundation | |
Utrecht Science Park | |
Hubrecht Organoid Technology Foundation | |
Mestag Therapeutics Ltd.
![]() Mestag Therapeutics Ltd. Financial ConglomeratesFinance Mestag Therapeutics Ltd. is engaged in the biotechnology industry. The company was founded on February 17, 2020 and is headquartered in Cambridge, the United Kingdom. | Finance |
Synox Therapeutics Ltd.
![]() Synox Therapeutics Ltd. BiotechnologyHealth Technology Synox Therapeutics Ltd. a clinical stage biopharmaceutical company. The company is headquartered in Dublin, Ireland. | Health Technology |
Forbion European Acquisition Corp.
![]() Forbion European Acquisition Corp. Financial ConglomeratesFinance Forbion European Acquisition Corp. is a blank check company. It engages in the business of effecting a merger, share exchange, asset acquisition, share purchase, reorganization, or similar business combination with one or more businesses or entities. The company was founded by Hugo Alexander Slootweg in 2006 and is headquartered in Wilmington, DE. | Finance |
- Börse
- Insiders
- Ton Logtenberg
- Erfahrung